Assessment of serum CXCL9 and pentraxin 3 as novel markers for hepatocellular carcinoma in cirrhotic hepatitis C patients

AIM OF THE STUDY: Hepatocellular carcinoma (HCC) is the most frequent primary cancer of the liver. It is also one of the world’s most common cancers and an important leading cause of cancer mortality in many parts of the world. As a result, it is essential to look for efficient markers for early and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehanna, Rafik Gabbour, Mohiedeen, Khaled, Kassem, Mohamed, Deghady, Akram, Abouelkheir, Hossam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090998/
https://www.ncbi.nlm.nih.gov/pubmed/37064830
http://dx.doi.org/10.5114/ceh.2023.125255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090998/
https://www.ncbi.nlm.nih.gov/pubmed/37064830
http://dx.doi.org/10.5114/ceh.2023.125255

Ejemplares similares